Suven Life Sciences disclosed a steady growth in standalone net profit for the quarter ended June 2014. During the quarter, the profit of the company rose 16.68% to Rs 347.38 million from Rs 297.72 million in the same quarter last year.
Net sales for the quarter rose 30.28% to Rs 1.42 million, compared with Rs 1 million for the prior year period.
Earnings per share for the quarter stood at Rs 2.97, registering 16.47% growth over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Jun - 14 | Jun - 13 | %Change |
| Net Sales | 1.42 | 1.09 | 30.28 |
| Net Profit | 347.38 | 297.72 | 16.68 |
| Basic EPS | 2.97 | 2.55 | 16.47 |
Shares of the company declined Rs 0.9, or 0.73%, to trade at Rs 122.60. The total volume of shares traded was 262,841 at the BSE (11.38 a.m., Tuesday).
